Ceryx Medical Initiates First-In-Human Study of the Cysoni™ RSA Pacemaker
Ceryx Medical notes the RSA-Pace study will enroll up to 60 patients at centers in the UK, New Zealand and Australia.
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
- Go to the previous page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- …
- 584
- Go to the next page